# Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer

> **NCT04986371** · — · UNKNOWN · sponsor: **Ling-Ying Wu** · enrollment: 300 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer

## Interventions

- **DRUG:** Niraparib

## Key facts

- **NCT ID:** NCT04986371
- **Lead sponsor:** Ling-Ying Wu
- **Sponsor class:** UNKNOWN
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-10
- **Primary completion:** 2022-08-31
- **Final completion:** 2025-02-28
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04986371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04986371, "Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04986371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*